Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
Project MYC is a critical transcription factor in most cancers, where it cooperates with many different protein complexes to activate diverse pro-tumorigenic pathways. Together with a senior postdoc in the
-
cutting-edge data science? And would you like to be part of a newly formed research collaboration between DTU and Novo Nordisk? Then you could be our new Postdoc. Read on to learn more! About the PhD
-
of code to utilize GPU-acceleration on DTU’s high-performance computing cluster or other HPC systems. You will also analyze realistic physical implementations of the architectures you explore, with a
-
interaction with the other PhDs/Postdocs and more senior scientists within the MicroAM project. Responsibilities and qualifications If you are interested in numerical simulations of advanced manufacturing
-
techniques (e.g., HR-TEM, HR-STEM, 4D-STEM, iDPC, ptychography) and their application to challenging hybrid materials. Curiosity about how ML/AI-driven data science can accelerate discovery and innovation in
-
, and expertise. The research group at CED works within and across the three departments. The group comprises six associate professors, four assistant professors, two postdocs, and five PhD-students
-
for accelerating characterisation and “state of health” monitoring. Testing of solid oxide cells under different operation conditions and microstructural characterisation after tests to identify degradation
-
passionate, curious, and driven individual, committed to accelerating the green transition by advancing autonomous solutions for wind power operations. You thrive on solving complex problems, ask bold and
-
professor, one assistant professor, one postdoc, and a large number of PhD students. The project includes strong partnerships with the University of Leipzig (Bioinformatics, Prof. Peter Stadler
-
sciences and advancing vaccine development. NIVI-R conducts scientific research, while NIVI-D works to quickly turn that research into new vaccine candidates. NIVI-D accelerates clinical trials (phases 1 and